Blog

Investors in life sciences and diagnostics company Danaher (NYSE: DHR) have enjoyed a relatively good 2020 so far, with the stock rising 4.4% compared to a 11% decline in the S&P 500 index. In

Shares of video game maker Activision Blizzard (NASDAQ: ATVI) have significantly outperformed competitors Electronic Arts (NASDAQ: EA) and Take-Two Interactive (NASDAQ: TTWO) year to date

The struggles faced by the cannabis industry are plentiful -- lower-than-expected revenue, rising black-market competition, regulatory scandals. Now with the COVID-19 pandemic, few cannabis

Stitch Fix (NASDAQ: SFIX) stock has taken a hit along with brick-and-mortar retailers due to the uncertainty arising from widespread unemployment and non-essential business closures. 

Data by YChar

Today's workers may not enjoy paying Social Security taxes on their incomes, but they do so because they have to and because of the promise that those benefits will be there when it's their turn to

For mortgage originators and mortgage servicers like PennyMac Financial Services (NYSE: PFSI), the current economic environment represents the best and the worst conditions.

Initial giddiness over

Insurance companies are facing some major headwinds in the second quarter. Not only are they confronted with the drag on earnings from a 0% interest rate environment, the industry is also faced with

Historically, during a pandemic, the demand for personal protective equipment (PPE) tends to fade rapidly after an outbreak subsides. If the coronavirus follows the same pattern, can Alpha Pro Tech

In some respects, Costco (NASDAQ: COST) and Dollar General (NYSE: DG) represent different ends of the retail spectrum. Costco has developed a reputation for delivering high-quality items in bulk

Looking back now, the last few weeks have been one of the biggest bonanzas investors have ever witnessed.

Since the market bottom on March 23, the S&P 500 has rallied as much as 35% in a little more

Plug Power (NASDAQ: PLUG) has been on a volatile path in the market for more than a decade. Since 2014, the company has also been on a high-potential path as big customers like Amazon.com and

For more than two months now, the coronavirus disease 2019 (COVID-19) has wreaked havoc on the U.S. economy and labor market. In total, more than 33 million people have filed for initial

Is now the right time to buy stocks?

It's a question that's usually followed by further rumination on whether the market has bottomed out, or if a new low might be coming. The reality is that nobody

Amid falling oil prices, Moody's hit ExxonMobil (NYSE: XOM) with a credit rating downgrade on April 2, 2020, downgrading Exxon's credit one notch from "Aaa" to "Aa1." That might not seem like much

Taxes on unemployment benefits? Yes, you read that right. Unemployment benefits are taxable income. And if you've recently claimed unemployment, you will need a plan to pay those taxes if you want

Shares of website-building platform Wix.com (NASDAQ: WIX) jumped on Wednesday after it reported a strong first quarter and provided a view into impressive performance during April. The company's

There's one number that stands out the most for Aurora Cannabis (NYSE: ACB) over the last 12 months -- 92%. That's how much Aurora's shares have plunged during the period. The marijuana version of

Image source: The Motley Fool.

Blue Bird Corporation (NASDAQ: BLBD)Q2 2020 Earnings CallMay 14, 2020, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Make no mistake about it: It's been a tough year so far for Green Thumb Industries (OTC: GTBIF) shareholders. The stock plunged more than 60% at one point and is still down 18% year to date. But the

Democrats in the House of Representatives recently announced a new "round four" stimulus package designed to help the United States economy weather the storm of the COVID-19 pandemic. The new

A group of Becton Dickinson (NYSE: BDX) shareholders are suing the healthcare company, claiming it didn't sufficiently disclose certain malfunctions of its Alaris infusion pumps product, thereby

If you look at most investors' portfolios, you'll typically see the bulk of their assets in stocks and stock-related mutual funds and ETFs. That makes sense, given how easy it is to invest in stocks

Companies that suffer dramatic declines in their share price typically look like poor investment options. More often than not, the phenomena illustrate that something has gone horribly wrong with

Unlike many other mid-cap biotech companies, shares of Fate Therapeutics (NASDAQ: FATE) are almost entirely owned by institutional investors. Just what exactly does the company have in its pipeline

For the past two months, mitigation measures meant to halt the spread of the coronavirus disease 2019 (COVID-19) have wreaked havoc on the U.S. economy and labor market. We've seen more than 33